CASI
CASI Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CASI Profile
Casi Pharmaceuticals, Inc.
A company that developing multi-mechanism oncology drugs
Biological Technology
--
06/12/1996
NASDAQ Stock Exchange
233
12-31
Common stock
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road, Chaoyang District, Beijing, 100025, People’s Republic of China
--
Kaixin Yuanda Pharmaceuticals was incorporated in 1991 and is an exempted company incorporated in the Cayman Islands. The Company is a biopharmaceutical company focused on the development and commercialization of innovative therapies and pharmaceutical products in China, the United States and around the world. The company has built a fully integrated, world-class biopharmaceutical company dedicated to the successful development and commercialization of innovative and other therapeutic products. The company's business development strategy is currently focused on acquiring additional targeted drugs and immuno-oncology therapies through licensing, which will expand the hematology/oncology franchise.
